Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Syed  Raza

Syed Raza

Awali Hospital, Bahrain

Title: Do we apply current guidelines while prescribing statin therapy?

Biography

Biography: Syed Raza

Abstract

Introduction: Statin  is the most  controversial  molecule , at the same time  very commonly  used  as well as misused  amongst all cardiovascukar  drugs.

Method : We  studied  a large  cohort of patients  to see  if  statin was being prescribed  by specialist  and general physicians  simply based  on their  random  clinical decision or current standard guidelines were  being followed.

Analysis and Results: It was discovered  that  a vast majority of patients  were being prescribed Statin simply based  on the numerical  value  of total  cholesterol and LDL levels.  A  cardiovascular  risk  approach  was not applied  in these patients.  On the other  hand  patients  particularly  diabetic  who are  now considered  at higher  risk  for cardiovascular event  were  being missed out on statin. Appropriate  potency  and  adequate  dosing  of statin  therapy was not always adhered to.  Statin therapy  was  also  discontinued  in patients despite strong clinical indication  simply based on mild rise in liver or muscle enzymes.  Use of Ezetemibe as adjunct therapy was very limited.

Conclusion: Standard  guidelines  are not always being used  while prescribing Statin treatment. Physicians  still tend to initiate  and stop statin thyerapy only based  on their own random clinical judgement. This action does  leave  some  high risk patients  unprotected  and made deprived  of  important  and readily available  drug therapy.